© Reuters.
On Monday, Wells Fargo upgraded shares of Masimo (NASDAQ:) Corporation (NASDAQ:MASI), a global medical technology company, from Equal Weight to Overweight, significantly increasing the price target to $160 from the previous $117.
This decision follows Masimo’s consideration of a potential separation of its consumer business, which Wells Fargo views as a highly positive move that could lead to an expansion of the company’s valuation multiple over time.
The analyst from Wells Fargo pointed out that the market has not fully embraced Masimo’s acquisition of Sound United, suggesting that a split would allow the company to refocus on its core healthcare (HC) business. The proposed separation is seen as a strategic step that could streamline operations and enhance investor perception of the company’s value.
Masimo, known for its innovative noninvasive monitoring technologies, has been under scrutiny by investors following its foray into consumer markets with the Sound United acquisition. The Wells Fargo analyst believes that by potentially dividing the consumer segment from the main healthcare-focused operations, Masimo could improve its growth prospects and market standing.
The upgraded rating and revised price target reflect confidence in Masimo’s management team to explore and execute strategic options that could benefit the company. Wells Fargo anticipates that these moves could lead to a reevaluation of Masimo’s stock by the investment community, potentially driving up its market value.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
